| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCITRANSLMED.3001707 |
| P698 | PubMed publication ID | 21248312 |
| P2093 | author name string | Pablo Cure | |
| Edward Connor | |||
| P2860 | cites work | Developing drugs for developing countries | Q28300802 |
| The economics of pediatric formulation development for off-patent drugs | Q33395888 | ||
| Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases | Q34137382 | ||
| Drug development for neglected diseases - the trouble with FDA review vouchers. | Q37318521 | ||
| Economic return of clinical trials performed under the pediatric exclusivity program | Q37412752 | ||
| More than baby steps: perspectives on pediatric translational research | Q39885779 | ||
| European perspectives on pediatric formulations | Q40016013 | ||
| Pediatric drug labeling: improving the safety and efficacy of pediatric therapies | Q44556060 | ||
| Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation | Q48771401 | ||
| P433 | issue | 66 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 66cm1 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Science Translational Medicine | Q1573955 |
| P1476 | title | "Creating hope" and other incentives for drug development for children | |
| P478 | volume | 3 |
| Q43682814 | An integrated approach to identifying clinically relevant targets in pediatric gliomas |
| Q33819758 | Analysis of pediatric clinical drug trials for neuropsychiatric conditions |
| Q34060045 | Declining childhood and adolescent cancer mortality |
| Q90261184 | Fostering open collaboration in drug development for paediatric brain tumours |
| Q49720626 | Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges |
| Q45594506 | How disease advocacy organizations participate in clinical research: a survey of genetic organizations |
| Q35688742 | Improving access to novel agents for childhood leukemia |
| Q28829289 | Integrated genetic and pharmacologic interrogation of rare cancers |
| Q49091558 | LC-UV/MS quality analytics of paediatric artemether formulations. |
| Q43529524 | New drugs for children and adolescents with cancer: the need for novel development pathways. |
| Q38258387 | New regulatory paradigms for innovative drugs to treat pediatric diseases. |
| Q37179472 | Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease. |
| Q35106844 | Remaining challenges in childhood cancer and newer targeted therapeutics |
| Q34253090 | The innovative medicines initiative: a European response to the innovation challenge |
Search more.